Theravance Biopharma Inc. (TBPH) slipped -5.51% or -1.34 to $22.97. It is approximately 97171 shares traded, which is 44.35% compare to the average total volume 219083. The market cap of TBPH is $1.26 billion. The year to date change is -13.4%. The 52 week price range is from $21.27 to $43.44. Price of TBPH have changed -4.74% during last week. It have changed 7.80% over last month, -13.82% over last 3 months, -14.82% over last 6 months and -32.13% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 24.64. It is 7.27% above current price. The 200-day Moving Averages for TBPH is 28.08. It is 22.25% above current price. The 52-week High is 43.44. It is 89.12% from the current price. The 52-week Low is 21.27. It is -7.40% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of TBPH is 25.65 on 2018-04-30. Short % to float is 12.19%. There are some statistics of TBPH. It is has market cap $1.26 billion. The share outstanding is 54.85 million. The average volume is 219083. The revenue is 7.78M. The gross profit is 5.44M. The percent of top 15 Institution holding is 84.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -141.32%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -49.14%.